Avivagen (VIVXF) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartShort Interest Avivagen Short Interest DataAvivagen (VIVXF) has a short interest of 1,900 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest1,900 sharesPrevious Short Interest1,900 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares77,690,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Avivagen? Sign up to receive the latest short interest report for Avivagen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVIVXF Short Interest Over TimeVIVXF Days to Cover Over TimeVIVXF Percentage of Float Shorted Over Time Ad StockEarningsPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-electedClaim your copy before they move Avivagen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,900 shares $0.00 No ChangeN/A0 $0.00 10/15/20241,900 shares $0.00 -59.6%N/A0.3 $0.00 9/30/20244,700 shares $0.00 -60.5%N/A3.4 $0.00 9/15/202411,900 shares $0.00 -16.8%N/A39.7 $0.00 8/31/202414,300 shares $51.48 No ChangeN/A0 $0.00 8/15/202414,300 shares $51.48 No ChangeN/A0 $0.00 Get the Latest News and Ratings for VIVXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter. 7/31/202414,300 shares $51.48 No ChangeN/A0 $0.00 7/15/202414,300 shares $51.48 No ChangeN/A0 $0.00 6/30/202414,300 shares $51.48 No ChangeN/A0 $0.00 6/15/202414,300 shares $51.48 No ChangeN/A142.5 $0.00 5/31/202414,300 shares $17.16 No ChangeN/A0 $0.00 5/15/202414,300 shares $17.16 No ChangeN/A143 $0.00 4/30/202414,300 shares $91.52 No ChangeN/A0 $0.01 4/15/202414,300 shares $91.52 -41.2%N/A7.2 $0.01 3/31/202424,300 shares $66.83 No ChangeN/A0 $0.00 3/15/202424,300 shares $66.83 No ChangeN/A4 $0.00 2/29/202424,300 shares $41.31 -29.2%N/A0 $0.00 2/15/202434,300 shares $142.35 -2.8%N/A9.5 $0.00 1/15/202435,300 shares $146.50 -24.7%N/A1 $0.00 12/31/202346,900 shares $28.14 No ChangeN/A0.4 $0.00 4/30/202344,100 shares $917.28 No ChangeN/A4 $0.02 10/31/20222,800 shares $285.88 No ChangeN/A28 $0.10 10/15/20222,800 shares $285.88 -64.6%N/A0.2 $0.10 9/30/20227,900 shares $966.96 No ChangeN/A0 $0.12 9/15/20227,900 shares $966.96 +182.1%N/A3.6 $0.12 8/31/20222,800 shares $352.24 No ChangeN/A0.2 $0.13 5/31/20221,900 shares $295.45 No ChangeN/A0.2 $0.16 5/15/20221,900 shares $304.00 +280.0%N/A0.2 $0.16 4/30/2022500 shares $75.00 No ChangeN/A0.2 $0.15 4/15/2022500 shares $78.40 No ChangeN/A0.3 $0.16 2/15/20225,100 shares $885.36 No ChangeN/A0.7 $0.17 1/31/20225,100 shares $1,198.50 +5,000.0%N/A0 $0.24 1/15/2022100 shares $23.50 No ChangeN/A0 $0.24 8/31/20212,000 shares $537.40 No ChangeN/A0.2 $0.27 6/30/20216,500 shares $2,263.30 +983.3%N/A0.5 $0.35 6/15/2021600 shares $207.54 No ChangeN/A0.1 $0.35 5/28/2021600 shares $229.20 -50.0%N/A0 $0.38 5/14/20211,200 shares $479.88 No ChangeN/A0.1 $0.40 3/31/202112,400 shares $4,905.44 +44.2%N/A0.5 $0.40 3/15/20218,600 shares $4,457.38 -5.5%N/A0.7 $0.52Popular Stocks at Risk Under Trump—Are You Holding These? (Ad)The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-electedClaim your copy before they move 2/26/20219,100 shares $4,443.53 -36.8%N/A0.2 $0.49 2/12/202114,400 shares $8,032.32 +48.5%N/A0.3 $0.56 1/29/20219,700 shares $4,171.00 +44.8%N/A0.3 $0.43 1/15/202114,300 shares $7,167.82 +45.9%N/A3.8 $0.50 12/31/20206,700 shares $3,198.58 -53.2%N/A3.5 $0.48 12/15/202014,300 shares $5,973.11 +45.9%N/A3.8 $0.42 11/30/20209,800 shares $3,954.30 +444.4%N/A2.3 $0.40 10/30/20202,100 shares $758.73 -4.6%N/A1.5 $0.36 10/15/20202,200 shares $0.00 -67.2%N/A0.3 $0.00 VIVXF Short Interest - Frequently Asked Questions What is Avivagen's current short interest? Short interest is the volume of Avivagen shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 1,900 shares of VIVXF short. Learn More on Avivagen's current short interest. How does Avivagen's short interest compare to its competitors? Here is how the short interest of companies in the industry of "private households" compare to Avivagen: Reliq Health Technologies Inc. (0.12%), Amadeus IT Group, S.A. (0.00%), Amplifon S.p.A. (1.64%), Aspen Pharmacare Holdings Limited (0.00%), Atlas Copco AB (0.00%), Bankinter, S.A. (0.00%), Blackstone Minerals Limited (0.00%), Bolloré SE (0.01%), Constellation Software Inc. (0.16%), Davide Campari-Milano (1.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Avivagen stock? Short selling VIVXF is an investing strategy that aims to generate trading profit from Avivagen as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avivagen? A short squeeze for Avivagen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIVXF, which in turn drives the price of the stock up even further. How often is Avivagen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIVXF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Reliq Health Technologies Short Interest A.P. Møller - Mærsk A/S Short Interest Amadeus IT Group Short Interest Amplifon Short Interest ANA Short Interest Aspen Pharmacare Short Interest Atlas Copco Short Interest Bankinter Short Interest Bayerische Motoren Werke Aktiengesellschaft Short Interest Beach Energy Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:VIVXF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avivagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIVXF Stock Alerts